Abstract
The finding of a relative absence of degeneration and regeneration in a muscle biopsy taken at 2½ weeks of age from a boy who later showed the florid pathological changes of preclinical Duchenne muscular dystrophy prompted a review of muscle biopsies taken from boys in the preclinical and early clinical stages of this disease. Only one other biopsy obtained in the first year of life was available. In this, taken at 2 months, there were active changes present. These findings suggest that biopsies taken to detect preclinical cases should not be performed at less than 2 months of age, and raise the possibility of the existence of a stage in Duchenne muscular dystrophy before active degeneration when the muscle shows little or no change on light microscopy.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Heyck H., Laudahn G., Carsten P. M. Enzymaktivitätsbestimmungen bei Dystrophia musculorum progressiva. IV. Die Serumenzymkinetik im präklinischen Stadium des Typus Duchenne während der ersten 2 Lebensjahre. Klin Wochenschr. 1966 Jun 15;44(12):695–700. doi: 10.1007/BF01790793. [DOI] [PubMed] [Google Scholar]
- Hudgson P., Pearce G. W., Walton J. N. Pre-clinical muscular dystrophy: histopathological changes observed on muscle biopsy. Brain. 1967 Sep;90(3):565–576. doi: 10.1093/brain/90.3.565. [DOI] [PubMed] [Google Scholar]
- PEARSON C. M. Histopathological features of muscle in the preclinical stages of muscular dystrophy. Brain. 1962 Mar;85:109–120. doi: 10.1093/brain/85.1.109. [DOI] [PubMed] [Google Scholar]
- PEARSON C. M. Serum enzymes in muscular dystrophy and certain other muscular and neuromuscular diseases. I. Serum glutamic oxalacetic transaminase. N Engl J Med. 1957 Jun 6;256(23):1069–1075. doi: 10.1056/NEJM195706062562301. [DOI] [PubMed] [Google Scholar]